For immunomodulation, TGF-β1-releasing PLGA materials have generated regulatory T cells and dendritic cells in vitro, as well as contributed to the delay in autoimmune progression of T1D and experimental autoimmune encephalomyelitis (EAE) (20, 31, 32). Here, TGFB1 is linked to type 1 diabetes mellitus.